Market Data 
Markets
Replies to post #48550 on Raadr Inc (RDAR)
08/19/25 5:17 PM
08/19/25 5:37 PM
Again as per OTC compliance OTC Alternative Reporting Companies like RDAR / Telvantis file Quarterly and Annual Reports with OTC Markets under the Alternative Reporting Standard.
Under OTC’s Disclosure Guidelines, companies must disclose Outstanding Shares (O/S) at period end.
Any material corporate events (like a buyback) in the Subsequent Events or Corporate Actions section.
RDAR's publicly announced timeline of
May 20, 2025 – Telvantis/RDAR announced brokerage account for buyback.
May 27, 2025 – Claimed buyback actually started.
From that point, they had a duty to disclose actual activity promptly (via a Material Event Report).
They were not allowed to wait until Q2 financials (due Aug 19, 2025) if any shares had actually been purchased.
As it was once brought up (wrongly) there is NO 5% threshold that triggers buyback disclosure like there is for beneficial ownership changes. Instead, companies must report all repurchases during the reporting period.
Now to affect the outstanding share count, shares must either be retired or returned to treasury. Simply buying through a brokerage account without retiring/returning doesn’t reduce the official outstanding shares.
Timing for RDAR’s case since RDAR/Televantis claims its buyback started May 27, 2025, then the Q2 disclosure (due August 19, 2025, by 5 PM EST) must contain full details of any repurchased shares.
If no change is reflected in the share structure by then, it could indicate either (a) no actual repurchases occurred, or (b) shares were bought but not yet retired/returned to treasur.
AI
